Societal CDMO, Inc. financial data

Symbol
SCTL on Nasdaq
Industry
Pharmaceutical Preparations
Location
1 E. Uwchlan Ave, Suite 112, Exton, Pennsylvania
State of incorporation
Pennsylvania
Fiscal year end
December 31
Former names
Recro Pharma, Inc. (to 3/21/2022)
Latest financial report
10-K - Q4 2023 - Mar 22, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 179 % -47%
Quick Ratio 42.5 % -30.7%
Debt-to-equity 166 % -35.7%
Return On Equity -23.4 % +49.6%
Return On Assets -8.8 % +32.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 111 M shares +30.2%
Common Stock, Shares, Outstanding 105 M shares +24%
Entity Public Float 94.3 M USD +123%
Common Stock, Value, Issued 1.05 M USD +24%
Weighted Average Number of Shares Outstanding, Basic 95.2 M shares +64.5%
Weighted Average Number of Shares Outstanding, Diluted 95.2 M shares +64.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 94.6 M USD +4.9%
Costs and Expenses 98.2 M USD +9.2%
Operating Income (Loss) -3.57 M USD -1381%
Nonoperating Income (Expense) 394 K USD +237%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -13.1 M USD +30%
Income Tax Expense (Benefit) 132 K USD -88.1%
Net Income (Loss) Attributable to Parent -13.3 M USD +33.2%
Earnings Per Share, Basic -0.14 USD/shares +58.8%
Earnings Per Share, Diluted -0.14 USD/shares +58.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.1 M USD -46%
Accounts Receivable, after Allowance for Credit Loss, Current 16.6 M USD +3.93%
Inventory, Net 10.3 M USD -0.38%
Assets, Current 53.5 M USD -3.82%
Property, Plant and Equipment, Net 49.8 M USD -1.13%
Operating Lease, Right-of-Use Asset 5 M USD -8.87%
Intangible Assets, Net (Excluding Goodwill) 2.24 M USD -23.5%
Goodwill 41.1 M USD 0%
Assets 153 M USD -2.52%
Accounts Payable, Current 1.31 M USD -10.5%
Employee-related Liabilities, Current 5.81 M USD +35.8%
Accrued Liabilities, Current 10.8 M USD -14.8%
Contract with Customer, Liability, Current 543 K USD -75.4%
Liabilities, Current 50 M USD +119%
Contract with Customer, Liability, Noncurrent 219 K USD
Operating Lease, Liability, Noncurrent 4.15 M USD -9.4%
Liabilities 94.8 M USD -2.84%
Retained Earnings (Accumulated Deficit) -279 M USD -5%
Stockholders' Equity Attributable to Parent 58.7 M USD -2%
Liabilities and Equity 153 M USD -2.52%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.85 M USD +64.7%
Net Cash Provided by (Used in) Financing Activities -2.47 M USD -1516%
Net Cash Provided by (Used in) Investing Activities -3.38 M USD -97.7%
Common Stock, Shares Authorized 185 M shares 0%
Common Stock, Shares, Issued 105 M shares +24%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.7 M USD +12.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.14 M USD -54.1%
Deferred Tax Assets, Valuation Allowance 54.3 M USD +6.69%
Deferred Tax Assets, Gross 68.5 M USD +7.07%
Operating Lease, Liability 5.26 M USD -7.15%
Depreciation 1.91 M USD +6.31%
Payments to Acquire Property, Plant, and Equipment 3.38 M USD +97.7%
Lessee, Operating Lease, Liability, to be Paid 8.26 M USD -12.4%
Property, Plant and Equipment, Gross 102 M USD +7.94%
Operating Lease, Liability, Current 1.11 M USD +2.41%
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3 M USD -20.3%
Deferred Tax Assets, Operating Loss Carryforwards 35.7 M USD +6.89%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 10 M shares 0%
Preferred Stock, Shares Outstanding 0 shares -100%
Amortization of Intangible Assets 687 K USD -24.1%
Deferred Tax Assets, Net of Valuation Allowance 14.2 M USD +8.56%
Share-based Payment Arrangement, Expense 5.01 M USD -7.69%
Interest Expense 9.96 M USD -29.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%